Hospitalizations and emergency attendance averted by influenza vaccination in Victoria, Australia, 2017 - 2019.


Journal

Epidemiology and infection
ISSN: 1469-4409
Titre abrégé: Epidemiol Infect
Pays: England
ID NLM: 8703737

Informations de publication

Date de publication:
04 Oct 2024
Historique:
medline: 4 10 2024
pubmed: 4 10 2024
entrez: 4 10 2024
Statut: epublish

Résumé

Seasonal influenza epidemics result in high levels of healthcare utilization. Vaccination is an effective strategy to reduce the influenza-related burden of disease. However, reporting vaccine effectiveness does not convey the population impacts of influenza vaccination. We aimed to calculate the burden of influenza-related hospitalizations and emergency department (ED) attendance averted by influenza vaccination in Victoria, Australia, from 2017 to 2019, and associated economic savings. We applied a compartmental model to hospitalizations and ED attendances with influenza-specific, and pneumonia and influenza (P&I) with the International Classification of Diseases, 10

Identifiants

pubmed: 39363589
doi: 10.1017/S0950268824001122
pii: S0950268824001122
doi:

Substances chimiques

Influenza Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e111

Auteurs

Catherine G A Pendrey (CGA)

National Centre for Epidemiology and Population Health, The Australian National University, Canberra, ACT, Australia.
WHO Collaborating Centre for Reference and Research on Influenza, Royal Melbourne Hospital, The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
Communicable Diseases, Health Protection Branch, Department of Health, Melbourne, VIC, Australia.

Arseniy Khvorov (A)

WHO Collaborating Centre for Reference and Research on Influenza, Royal Melbourne Hospital, The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
Department of Infectious Diseases, University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.

Son Nghiem (S)

College of Health and Medicine, Australian National University, Canberra, ACT, Australia.

Md R Rahaman (MR)

National Centre for Epidemiology and Population Health, The Australian National University, Canberra, ACT, Australia.

Janet Strachan (J)

Communicable Diseases, Health Protection Branch, Department of Health, Melbourne, VIC, Australia.

Sheena G Sullivan (SG)

WHO Collaborating Centre for Reference and Research on Influenza, Royal Melbourne Hospital, The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
Department of Infectious Diseases, University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
Department of Epidemiology, University of California, Los Angeles, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH